Drugs News and Research

RSS

Scientists discover novel compound to combat age-related blindness

Rensselaer Polytechnic Institute's Christopher Cioffi, Ph.D., Thomas and Constance D'Ambra Professor in Organic Chemistry, has been collaborating with Konstantin Petrukhin, Ph.D., Professor of Ophthalmic Science at Colombia University, to develop compounds to treat dry age-related macular degeneration (AMD) and Stargardt disease - both blindness-causing diseases.

28 Oct 2024

Research identifies respiratory transmission potential of H5N1 virus

A highly pathogenic avian influenza (HPAI) H5N1 virus, isolated from the eye of a farm worker who became infected through contact with dairy cows, was lethal in mice and ferrets infected in a high-containment laboratory environment, according to a new study in Nature.

28 Oct 2024

Wayne State University receives NIH grant for innovative drug design research

A grant from the National Institutes of Health will help Wayne State University researchers explore new avenues for using computer models to produce medications.

28 Oct 2024

New research unveils mechanism behind deadly neuroendocrine prostate cancer

A leading scientist whose discoveries about prostate cancer led to lifesaving treatments is now shedding light on an emerging and deadlier form of the disease: neuroendocrine prostate cancer (NEPC).

28 Oct 2024

Global leaders gather at the NFCR Summit to drive breakthroughs in cancer care

The 2024 National Foundation for Cancer Research (NFCR) Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, co-hosted with the AIM-HI Accelerator Fund, convened the world's top experts across cancer research, biotech entrepreneurship, pharmaceuticals, investment, and patient advocacy.

28 Oct 2024

NIH grants $2.6 million to explore the effects of high blood-pressure drugs in CKD patients

The National Institutes of Health awarded a four-year, $2.6 million grant to researchers at Case Western Reserve University to study how high blood-pressure drugs affect patients with chronic kidney disease (CKD).

28 Oct 2024

UC San Diego receives $8 million grant to study the genetics of substance use disorder

University of California San Diego School of Medicine has received a five-year, $8 million grant from the National Institute on Drug Abuse (NIDA) to study the genetics of substance use disorders.

28 Oct 2024

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Heather Snyder discusses the Alzheimer's Association's research initiatives, breakthroughs in diagnostics, and the importance of collaboration in dementia care.

28 Oct 2024

Evosep expanding capabilities with new headquarters to support rising needs in pharma and biotech for proteomics

...

From Evosep 28 Oct 2024

Bedfont® Scientific Limited Host an Insightful Panel Discussion in Recognition of Stoptober

Stoptober takes place every October in the UK. The campaign encourages smokers to quit for 28 days.

From Bedfont® Scientific Ltd 28 Oct 2024

New research explores how antimicrobial exposure affects Parkinson’s disease risk

Antibiotic exposure shows potential protective effects against Parkinson's, while antifungal use is linked to increased risk, indicating microbiome involvement.

28 Oct 2024

Expanded access to weight-loss drugs could save thousands of lives

Researchers explore the potential benefits of expanding access to novel weight loss drugs to enhance survival rates in overweight and obese individuals.

28 Oct 2024

Unlocking the secrets of Usher syndrome

The mistakes are small but carry severe consequences: In Usher syndrome, genetic mutations cause both hearing and vision loss. Cell biologist Professor Uwe Wolfrum from Mainz University is researching the molecular background of this rare genetic disorder - supported by foundations and, not least, by affected individuals themselves

28 Oct 2024

Study: GLP-1RA not associated with acute kidney injury risk during anti-cancer treatments

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA–associated acute kidney injury (AKI) have emerged, but the risk of GLP-1RA–associated AKI among patients on anti-cancer drugs is unclear.

26 Oct 2024

The importance of muscle preservation in medically induced weight loss

A recent commentary published in The Lancet journal highlights the critical importance of skeletal muscle mass in the context of medically induced weight loss, particularly with the widespread use of GLP-1 receptor agonists.

26 Oct 2024

Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity

The diabetes drug semaglutide, also known as Ozempic, has a positive effect for patients with chronic kidney damage and obesity. They

26 Oct 2024

Pioneering trial to test multiple new treatments for glioblastoma

A pioneering research study announced today (October 23) will trial multiple new treatments for people in the UK living with glioblastoma, an aggressive form of brain cancer.

26 Oct 2024

Surge in GLP-1 drug use for obesity coincides with drop in bariatric surgery

Researchers from Mass General Brigham and collaborators found that use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023 while rates of surgery dropped by one quarter.

26 Oct 2024

Tiny magnetic soft robots pave the way for targeted drug delivery

A team of scientists at Nanyang Technological University, Singapore (NTU Singapore) has developed grain-sized soft robots that can be controlled using magnetic fields for targeted drug delivery, paving the way to possible improved therapies in future.

25 Oct 2024

Researchers unlock potential of light-controlled cellular activities

Researchers at the Paul Scherrer Institute PSI have succeeded in elucidating the structure of specific photoreceptors.

25 Oct 2024

Drugs News and Research

Scientists discover novel compound to combat age-related blindness

Research identifies respiratory transmission potential of H5N1 virus

Wayne State University receives NIH grant for innovative drug design research

New research unveils mechanism behind deadly neuroendocrine prostate cancer

Global leaders gather at the NFCR Summit to drive breakthroughs in cancer care

NIH grants $2.6 million to explore the effects of high blood-pressure drugs in CKD patients

UC San Diego receives $8 million grant to study the genetics of substance use disorder

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Evosep expanding capabilities with new headquarters to support rising needs in pharma and biotech for proteomics

Bedfont® Scientific Limited Host an Insightful Panel Discussion in Recognition of Stoptober

New research explores how antimicrobial exposure affects Parkinson’s disease risk

Expanded access to weight-loss drugs could save thousands of lives

Unlocking the secrets of Usher syndrome

Study: GLP-1RA not associated with acute kidney injury risk during anti-cancer treatments

The importance of muscle preservation in medically induced weight loss

Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity

Pioneering trial to test multiple new treatments for glioblastoma

Surge in GLP-1 drug use for obesity coincides with drop in bariatric surgery

Tiny magnetic soft robots pave the way for targeted drug delivery

Researchers unlock potential of light-controlled cellular activities

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News